New episodes every Tuesday!
GET NEW EPISODES TO YOUR EMAIL
Latest Episode
Living in the Now, with John Doe
Adipiscing elit dapibus, vulpu tate in donec tempor ultricies venenatis erat, aliquam posuere urna habitant rutrum iaculis Euismod maecenas varius. tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam
Honda and Nissan have made merger talks official. Why Honda’s U.S.-listed shares are flying.
Honda was looking at the second-biggest one-day percentage gain since Oct. 28, 2008.
Two-year slump among U.S. manufacturers shows little sign of ending
American manufacturers might be more optimistic about ending a two-year slump after a business friendly Trump administration takes over in 2025, but they are ending the current year on a sour note.
Fund managers see AI delivering big gains for these 5 stocks — including Duolingo
These innovative companies are using artificial intelligence in ways that can boost earnings growth.
The coming global interest-rate collapse will force four Fed-rate cuts in 2025
Economic pain worldwide will trigger capital flight to U.S. Treasurys, driving down those yields, investment manager Louis Navellier says. The Fed will follow.
Oil prices begin week on down note
Oil futures traded modestly lower early Monday, extending a decline seen the previous week in response to a surging U.S. dollar and worries about the outlook for demand, particularly from China, the world’s largest crude importer.
Hyatt may add hotels in Mexico, Jamaica with potential Playa merger
Playa Hotels & Resorts NV’s stock was rallying 11% in premarket trading on Monday after the company said it agreed to enter into exclusive strategic talks with Hyatt Hotels Corp. in a move that would boost the larger hotel chain’s presence in Jamaica, Mexico and...
Here are the year’s losing stocks that could see a big rebound in early 2025
Tax-loss selling candidates such as Nike, could surprise investors with big gains in 2025, say Evercore strategists.
Novo Nordisk’s 27% drop was market overreaction, analysts say
Trials of semaglutide in patients with Alzheimer’s and CagriSema in obese patients diabetes could give investors reason to be optimistic, Intron Health’s analysts said
‘I’ve always been very good with money’: Should I put my wife on the title of our family home, investment property and my late father’s house?
“If I die and she sells the properties, would she have to pay a lot of capital-gains taxes, especially on the houses we don’t live in?”
Stay Tuned For Our Latest Episodes
Anean eu enim justo. Vestibulum aliquam hende rit molestie. Mauris malesuada nisi sit amet augue accumsan tincidunt. Maecenas tincidunt aliquam hende rit molestie. Mauris malesuada.
Start Listening Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas varius tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam hendrerit